CMS Targeting Georgia, Ohio in Fraud Fight

Why It Matters

By tightening oversight in fast‑growing hospice markets, CMS aims to curb billing fraud that threatens Medicare sustainability while preserving care quality for vulnerable patients.

Key Takeaways

• CMS extends enhanced oversight to Georgia and Ohio, retroactive Dec 31, 2025.
• Ohio hospice count grew from 6 to 45 in Montgomery County.
• Georgia now has over 300 hospice providers, 76 operating in Fulton County.
• Oversight adds pre‑payment claim reviews and penalties up to Medicare removal.
• Legitimate hospices welcome scrutiny but fear unintended impact on rural access.

Pulse Analysis

CMS’s decision to expand its provisional enhanced‑oversight program reflects a broader federal push to police hospice billing amid a wave of market entry. The original pilot, launched in 2023 for four states long associated with fraud, introduced pre‑payment medical reviews and heightened audit frequency. By extending the regime to Georgia and Ohio, regulators signal that rapid provider proliferation—often outpacing genuine patient demand—will trigger closer scrutiny. This move aligns with Medicare’s strategic objective to protect the program’s financial integrity while maintaining confidence among beneficiaries and payers.

In Ohio, the hospice landscape has transformed dramatically. Montgomery County alone now hosts 45 providers, up from just six in 2010, and the statewide count approaches 200. Similar dynamics play out in Georgia, where more than 300 hospices operate, with Fulton County seeing 76 distinct entities despite the state lacking a Certificate of Need requirement. Such density raises red flags about unnecessary services, duplicate billing, and potential upcoding. For patients, the influx can dilute care coordination, while for legitimate nonprofits, it intensifies competition for referrals and reimbursement.

The enhanced‑oversight framework imposes pre‑payment claim reviews, extended monitoring periods of 30 days to a year, and steep penalties, including claim denials and removal from Medicare. While established hospices view the added layer as a validation of ethical practice, rural providers fear being caught in a broad‑brush sweep that could limit access in underserved areas. Balancing fraud deterrence with equitable care delivery will require CMS to fine‑tune its criteria, perhaps by incorporating risk‑based targeting rather than blanket application. The coming months will reveal whether the oversight curtails abusive billing without stifling legitimate hospice growth.